ReP USP - Resultado da busca

Filtros : "Jürgensmeier, J. M." Limpar

Filtros

USP affiliated authors
- hoff, paulo marcelo gehm (~2)
Date published
- 2013 (~2)
Subjects
- biomarcadores (2)
- antineoplásicos (aplicações terapêuticas) (1)
- metástase neoplásica (1)
- neoplasias (prevenção e controle) (1)
- neoplasias colorretais (terapia) (1)

Artigo de periodico
Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy (2013)
Jürgensmeier, J. M.; Schmoll, H-J; Robertson, J. D.; Brooks, L.; Taboada, M.; Morgan, S. R.; Wilson, D.; Hoff, P. M.
Source: British Journal of Cancer. Unidade: FM
Subjects: BIOMARCADORES, NEOPLASIAS (PREVENÇÃO E CONTROLE)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JÜRGENSMEIER, J. M. et al. Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy. British Journal of Cancer, v. 108, n. 6, p. 1316-1323, 2013Tradução . . Disponível em: https://doi.org/10.1038/bjc.2013.79. Acesso em: 17 maio 2024.
APA
Jürgensmeier, J. M., Schmoll, H. -J., Robertson, J. D., Brooks, L., Taboada, M., Morgan, S. R., et al. (2013). Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy. British Journal of Cancer, 108( 6), 1316-1323. doi:10.1038/bjc.2013.79
NLM
Jürgensmeier JM, Schmoll H-J, Robertson JD, Brooks L, Taboada M, Morgan SR, Wilson D, Hoff PM. Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy [Internet]. British Journal of Cancer. 2013 ; 108( 6): 1316-1323.[citado 2024 maio 17 ] Available from: https://doi.org/10.1038/bjc.2013.79
Vancouver
Jürgensmeier JM, Schmoll H-J, Robertson JD, Brooks L, Taboada M, Morgan SR, Wilson D, Hoff PM. Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy [Internet]. British Journal of Cancer. 2013 ; 108( 6): 1316-1323.[citado 2024 maio 17 ] Available from: https://doi.org/10.1038/bjc.2013.79
Artigo de periodico
Prognostic/predictive value of 207 serum factors in colorectal cancer treated with cediranib and/or chemotherapy (2013)
Spencer, S. K. M.; Pommier, A. J. C.; Morgan, S. R.; Barry, S. T.; Robertson, J. D.; Hoff, P. M.; Jürgensmeier, J. M.
Source: British Journal of Cancer. Unidade: FM
Subjects: BIOMARCADORES, NEOPLASIAS COLORRETAIS (TERAPIA), ANTINEOPLÁSICOS (APLICAÇÕES TERAPÊUTICAS), PROGNÓSTICO, METÁSTASE NEOPLÁSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SPENCER, S. K. M. et al. Prognostic/predictive value of 207 serum factors in colorectal cancer treated with cediranib and/or chemotherapy. British Journal of Cancer, v. 109, n. 11, p. 2765-2773, 2013Tradução . . Disponível em: https://doi.org/10.1038/bjc.2013.649. Acesso em: 17 maio 2024.
APA
Spencer, S. K. M., Pommier, A. J. C., Morgan, S. R., Barry, S. T., Robertson, J. D., Hoff, P. M., & Jürgensmeier, J. M. (2013). Prognostic/predictive value of 207 serum factors in colorectal cancer treated with cediranib and/or chemotherapy. British Journal of Cancer, 109( 11), 2765-2773. doi:10.1038/bjc.2013.649
NLM
Spencer SKM, Pommier AJC, Morgan SR, Barry ST, Robertson JD, Hoff PM, Jürgensmeier JM. Prognostic/predictive value of 207 serum factors in colorectal cancer treated with cediranib and/or chemotherapy [Internet]. British Journal of Cancer. 2013 ; 109( 11): 2765-2773.[citado 2024 maio 17 ] Available from: https://doi.org/10.1038/bjc.2013.649
Vancouver
Spencer SKM, Pommier AJC, Morgan SR, Barry ST, Robertson JD, Hoff PM, Jürgensmeier JM. Prognostic/predictive value of 207 serum factors in colorectal cancer treated with cediranib and/or chemotherapy [Internet]. British Journal of Cancer. 2013 ; 109( 11): 2765-2773.[citado 2024 maio 17 ] Available from: https://doi.org/10.1038/bjc.2013.649

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024